Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 49, Issue 11 (Nov 2011)

Issues

Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort

Edzard Schwedhelm
  • Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Vanessa Xanthakis
  • Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
  • Framingham Heart Study, Framingham, MA, USA
  • Preventive Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Renke Maas
  • Institute of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen, Erlangen, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Lisa M. Sullivan
  • Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
  • Framingham Heart Study, Framingham, MA, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Dorothee Atzler
  • Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Nicole Lüneburg
  • Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Nicole L. Glazer
  • Framingham Heart Study, Framingham, MA, USA
  • Preventive Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Ulrich Riederer / Ramachandran S. Vasan
  • Framingham Heart Study, Framingham, MA, USA
  • Preventive Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA
  • Cardiology Sections, Department of Medicine, Boston University School of Medicine, Boston, MA, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Rainer H. Böger
  • Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2011-08-25 | DOI: https://doi.org/10.1515/cclm.2011.679

Abstract

Background: Symmetric dimethylarginine (SDMA) is a by-product of protein methylation. Once released from proteins, SDMA is eliminated by the kidneys; consequently, plasma concentration has been suggested as a sensitive marker of renal function. Furthermore, recent work implicates SDMA in the pathogenesis of cardiovascular disease. To date, reference limits for SDMA plasma concentrations in healthy individuals are lacking.

Methods: This study defined reference limits for plasma SDMA concentrations in 840 relatively healthy individuals of the Offspring Cohort from Framingham Heart Study (mean age 56 years, 61% women). Plasma SDMA concentrations were determined by LC-MS/MS using a stable isotope dilution assay.

Results: The median SDMA concentration in the reference sample was 0.37 μmol/L (Q1, Q3:0.32, 0.43 μmol/L) and the reference limits were 0.225 and 0.533 (2.5th and 97.5th percentile). In a multivariable regression model, serum creatinine, age and total homocysteine were positively associated with SDMA (p<0.001 for all), whereas the body mass index and diastolic blood pressure were inversely related to SDMA (p-values<0.01 and 0.03, respectively).

Conclusions: This study reports plasma SDMA reference limits from the community-based Framingham Heart Study. Plasma SDMA concentration was related positively to advancing age, but inversely to renal function. These reference limits may allow the identification of individuals with raised plasma SDMA concentrations.

Keywords: Framingham Heart Study; LC-MS/MS; symmetric dimethylarginine

About the article

Corresponding author: Edzard Schwedhelm, Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Fax: 49-40-741059757


Received: 2011-04-05

Accepted: 2011-07-26

Published Online: 2011-08-25

Published in Print: 2011-11-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm.2011.679.

Export Citation

©2011 by Walter de Gruyter Berlin Boston. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Julie Lorin, Jean-Claude Guilland, Karim Stamboul, Charles Guenancia, Yves Cottin, Luc Rochette, Catherine Vergely, Marianne Zeller, and Carmine Pizzi
PLOS ONE, 2017, Volume 12, Number 1, Page e0169979
[2]
Anja Kittel, Fabian Müller, Jörg König, Maren Mieth, Heinrich Sticht, Oliver Zolk, Ana Kralj, Markus R. Heinrich, Martin F. Fromm, Renke Maas, and Takeo Yoshikawa
PLoS ONE, 2014, Volume 9, Number 2, Page e88544
[3]
Sabrina Schlesinger, Svenja R. Sonntag, Wolfgang Lieb, Renke Maas, and Tatsuo Shimosawa
PLOS ONE, 2016, Volume 11, Number 11, Page e0165811
[4]
Arduino A. Mangoni, Angelo Zinellu, Ciriaco Carru, John R. Attia, Mark McEvoy, and Florian Kronenberg
PLoS ONE, 2013, Volume 8, Number 1, Page e54870
[5]
Jessica A. Hokamp and Mary B. Nabity
Veterinary Clinical Pathology, 2016, Volume 45, Number 1, Page 28
[6]
Catharina M. C. Mels, Ilisma Loots, Edzard Schwedhelm, Dorothee Atzler, Rainer H. Böger, and Aletta E. Schutte
Amino Acids, 2016, Volume 48, Number 3, Page 801
[7]
Maike Anderssohn, Stela McLachlan, Nicole Lüneburg, Christine Robertson, Edzard Schwedhelm, Rachel M. Williamson, Mark W.J. Strachan, Ramzi Ajjan, Peter J. Grant, Rainer H. Böger, and Jackie F. Price
Diabetes Care, 2014, Volume 37, Number 3, Page 846
[8]
Hege Pihlstrøm, Geir Mjøen, Dag Olav Dahle, Stefan Pilz, Karsten Midtvedt, Winfried März, Sadollah Abedini, Ingar Holme, Bengt Fellström, Alan Jardine, and Hallvard Holdaas
Transplantation, 2014, Volume 98, Number 11, Page 1219
[9]
J.A. Hall, M. Yerramilli, E. Obare, M. Yerramilli, and D.E. Jewell
Journal of Veterinary Internal Medicine, 2014, Volume 28, Number 6, Page 1676
[10]
Luigi Servillo, Alfonso Giovane, Domenico Cautela, Domenico Castaldo, and Maria Luisa Balestrieri
Nitric Oxide, 2013, Volume 30, Page 43
[11]
Hendrik Veldink, Robert Faulhaber-Walter, Joon-Keun Park, Jens Martens-Lobenhoffer, Stefanie Bode-Böger, Harald Schuett, Arash Haghikia, Denise Hilfiker-Kleiner, and Jan T. Kielstein
Nephrology Dialysis Transplantation, 2013, Volume 28, Number 6, Page 1434
[12]
Joachim Strobel, Maren Mieth, Beate Endreß, Daniel Auge, Jörg König, Martin F. Fromm, and Renke Maas
Journal of Molecular and Cellular Cardiology, 2012, Volume 53, Number 3, Page 392

Comments (0)

Please log in or register to comment.
Log in